Sector: Pharmaceuticals & Biotechnology

Small Cap

MPS Pharma Share Price

Q: What is the Market Capitalization of MPS Pharma Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 2 June 2025, the market cap for MPS Pharma Ltd. is approximately ₹ 3.5 Cr.

Q: What are the PE and PB ratios for MPS Pharma Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for MPS Pharma Ltd. is -3.4, and the Price-to-Book (PB) ratio is 50.6.

Q: What is the 52-Week High and Low for MPS Pharma Ltd.?

Over the past 52 weeks, the highest price reached by MPS Pharma Ltd. shares was ₹ 2.86, and the lowest price was ₹ 1.57.

Q: Who are the major shareholders of MPS Pharma Ltd.?

Significant shareholdings in MPS Pharma Ltd. typically include entities such as: Public Promoter Other Institutions (Note: Shareholding patterns can change; this represents major holders based on recent filings).

Q: Who are the peers of MPS Pharma Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, MPS Pharma Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

ADVIKLA

₹1.81

0.00(0.00%)

No Graph

NSE :

Open Free Demat Account

MPS Pharma Performance

Price Movement

N/A

₹1.81

↘ Today's Low↗ Today's High

1 Year Performance

Data is not available

Markets Today

High₹1.81

Low₹1.81

Open at₹1.81

Prev Close₹1.81

Volumes100

Avg Price₹1.81

Lower Circuit₹0.00

Upper Circuit₹0.00

Historical Performance

3M High₹1.81

3M Low₹1.71

1 Yr High₹2.86

1 Yr Low₹1.57

3 Yr High₹4.33

3 Yr Low₹1.57

5 Yr High₹4.33

5 Yr Low₹1.11

Summary

As of 10-07-2026 20:01, MPS Pharma Ltd. share price today is ₹0, with a change of ₹-1.81 (-100.00%) from the previous close of ₹1.81. The stock opened at ₹1.81 and traded between ₹1.81 and ₹1.81, with a total traded volume of 100 shares. The company has a market capitalization of ₹3.5 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹2.86 and ₹1.57, respectively.

MPS Pharma Ltd. valuation metrics include a P/E ratio of -3.4, and book value of ₹50.60. Profitability indicators show ROE of -1489.05%. MPS Pharma Ltd. has reported net profit of ₹-1.02 Cr.

MPS Pharma Ltd. technical indicators include Day RSI at 43.57, Day MFI at 36.38, Day ADX at 34.88. Additional indicators include Commodity Channel Index (CCI) at 86. Momentum indicators show Day MACD at -0.08, Day MACD Signal Line at -0.13, DayATR at 0.05. Rate of Change indicators for MPS Pharma Ltd. include ROC125 at -28.74 and ROC21 at 2.84.

Exponential moving averages include EMA5 at ₹1.8, EMA10 at ₹1.8, EMA12 at ₹1.8, EMA20 at ₹1.8, EMA26 at ₹1.9, EMA50 at ₹2.1, EMA100 at ₹2.4, EMA200 at ₹2.4. Simple moving averages include SMA5 at ₹1.8, SMA10 at ₹1.8, SMA20 at ₹1.7, SMA30 at ₹1.8, SMA50 at ₹2.1, SMA100 at ₹2.9, SMA150 at ₹2.8, SMA200 at ₹2.5.

Support levels for MPS Pharma are placed at First Support ₹1.81, Second Support ₹1.81, Third Support ₹1.81. Resistance levels are seen at First Resistance ₹1.81, Second Resistance ₹1.81, Third Resistance ₹1.81. MPS Pharma Ltd. shareholding pattern shows promoter holding at 35.89%, FII holding at 0%, DII holding at 0%, public holding at 63.53%.

MPS Pharma Fundamentals

Market Cap

Low in industry

3.50 Cr.

PE Ratio (TTM)

Negative PE TTM

-3.40

Dividend Yield

Net Profit TTM

13% decr over last year

-1.02

Net Profit Growth

13% decr over last year

-1.02

PEG Ratio

Above industry Median

0.20

ROE

1692% decr over last year

-1,489.05

Operating Revenue TTM

Operating Revenue Growth

Book Value

High in industry

50.60

MFI

MFI is mid-range

36.38

RSI

RSI is mid-range

43.57

EPS (TTM)

Debt to Equity

Face Value

Operating Profit Margin Qtr.

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

50.60

MPS Pharma Financials

Data not available for chart

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	0	0	0	0	0
Operating Expense	0.37	0.19	0.19	0.19	0.19
Operating Profit	-0.37	-0.19	-0.19	-0.19	-0.19
Depreciation	0.04	0.04	0.04	0.04	0.04
Interest	0	0	0	0	0
Tax	-0.01	-0.01	-0.01	-0.01	0.05
Net Profit	-0.36	-0.22	-0.22	-0.22	-0.28

MPS Pharma Technicals

MPS Pharma Ltd. EMA & SMA

₹1.81

0.00 (0.00%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹1.8

Day EMA10 ₹1.8

Day EMA12 ₹1.8

Day EMA20 ₹1.8

Day EMA26 ₹1.9

Day EMA50 ₹2.1

Day EMA100 ₹2.4

Day EMA200 ₹2.4

MPS Pharma Support and Resistance

Resistance

First Resistance₹1.81

Second Resistance₹1.81

Third Resistance₹1.81

Support

First Support₹1.81

Second Support₹1.81

Third Support₹1.81

Technical Indicators

Day RSI43.57

Day MFI36.38

Day ADX34.88

Day Commodity Channel Index86.00

William-

Day MACD-0.08

Day MACD Signal Line-0.13

Day ATR0.05

Day ROC125-28.74

Day ROC212.84

MPS Pharma Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	35.9	35.9	35.9	35.9	35.9	35.9
FII	0	0	0	0	0	0
DII	0.6	0.6	0.6	0.6	0.6	0.6
Public	63.5	63.5	63.5	63.5	63.5	63.5

MPS Pharma Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	100	100	100.00%
Week	100	100	100.00%
1 Month	0	0	undefined%
6 Month	1.63 K	1.63 K	100.00%

MPS Pharma SWOT Analysis

Strengths3

Weakness12

Opportunity0

Threats0

Rising Net Cash Flow and Cash from Operating activity

PEG lower than Industry PEG

Stock with Low PE (PE < = 10)

MPS Pharma Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

MPS Pharma Stock Comparison

Financials	Goldline Pharmaceutical Ltd.	Sai Parenterals Ltd.	Speciality Medicines Ltd.	Accretion Nutraveda Ltd.	Rekvina Laboratories Ltd.	Vivimed Labs Ltd.
Price (₹)	₹41	₹587.60	₹183.50	₹259.30	₹35	₹5.40
% Change	0.00%	-1.43%	-0.27%	0.00%	-2.78%	-0.18%
Revenue TTM (₹ Cr)	-	-	-	-	₹1.27	₹83.60
Net Profit TTM (₹ Cr)	-	-	-	-	₹-0.25	₹-34.95
PE TTM	9.60	-	12.40	37.00	-85.20	-1.30
1 Year Return		52.07			700	441
ROCE	-	3.56	-	-	-	-5.63

Similar Stocks

APPL

Aptus Pharma Ltd.

₹ 224.00

+1.93%

AMANTA

Amanta Healthcare Ltd.

₹ 179.17

-2.00%

AHCL

Anlon Healthcare Ltd.

₹ 15.60

+0.84%

PATELCHEM

Patel Chem Specialities Ltd.

₹ 95.00

-1.04%

APL

Asston Pharmaceuticals Ltd.

₹ 76.50

+1.32%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 535.00

-0.10%

ASTONEALAB

Astonea Labs Ltd.

₹ 282.55

+1.99%

AMWILL

Amwill Health Care Ltd.

₹ 41.00

-3.91%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 62.00

-0.26%

SHELTER

Shelter Pharma Ltd.

₹ 27.40

+6.41%

TLL

Trident Lifeline Ltd.

₹ 262.50

-0.61%

DPL

Dipna Pharmachem Ltd.

₹ 5.76

-8.86%

ACHYUT

Achyut Healthcare Ltd.

₹ 8.20

+0.12%

SIGACHI

Sigachi Industries Ltd.

₹ 22.67

+1.98%

WINDLAS

Windlas Biotech Ltd.

₹ 830.00

+0.50%

VINEETLAB

Vineet Laboratories Ltd.

₹ 32.80

+0.43%

CBPL

Chandra Bhagat Pharma Ltd.

₹ 38.55

-4.98%

CHCL

Cian Healthcare Ltd.

₹ 8.67

+0.00%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 568.90

+0.36%

RAJNISH

Rajnish Wellness Ltd.

₹ 0.41

+0.00%

ZIMLAB

Zim Laboratories Ltd.

₹ 113.62

-1.99%

BPLPHARMA

Bharat Parenterals Ltd.

₹ 1402.00

-0.61%

MEDICO

Medico Remedies Ltd.

₹ 39.10

+0.03%

SGRL

Shree Ganesh Remedies Ltd.

₹ 687.00

+1.43%

FAQ's on ADVIKLA

What is the Market Capitalization of MPS Pharma Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 2 June 2025, the market cap for MPS Pharma Ltd. is approximately ₹ 3.5 Cr.

What are the PE and PB ratios for MPS Pharma Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for MPS Pharma Ltd. is -3.4, and the Price-to-Book (PB) ratio is 50.6.

What is the 52-Week High and Low for MPS Pharma Ltd.?

Over the past 52 weeks, the highest price reached by MPS Pharma Ltd. shares was ₹ 2.86, and the lowest price was ₹ 1.57.

Who are the major shareholders of MPS Pharma Ltd.?

Significant shareholdings in MPS Pharma Ltd. typically include entities such as:

Public
Promoter
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of MPS Pharma Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, MPS Pharma Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy